Pharmaceuticals 2010, 3(12), 3581-3593; doi:10.3390/ph3123581
Review

Artemisinin-Naphthoquine Combination (ARCO®): An Overview of the Progress

1 Centre for Health Research, Divine Word University, P O Box 483, Madang 555, Madang Province, Papua New Guinea 2 Medical Research Institute, Kunming Pharma, West suburb, Xishan Region, Kunming, China
* Author to whom correspondence should be addressed.
Received: 15 November 2010; in revised form: 8 December 2010 / Accepted: 9 December 2010 / Published: 14 December 2010
(This article belongs to the Special Issue New Antimalarial Drugs)
PDF Full-text Download PDF Full-Text [205 KB, uploaded 14 December 2010 10:39 CET]
Abstract: With the rapidly spreading resistance of Plasmodium falciparum to available non-artemisinin antimalarial drugs, new and novel pharmaceuticals are needed. ARCO® is a new generation ACT, one of several artemisinin-based combinations developed in China to counter antimalarial drug resistance. ARCO® is a derivative of two independently developed antimalarials, artemisinin and naphthoquine phosphate, which were combined to form the artemisinin-naphthoquine combination. Both artemisinin and naphthoquine drugs have proven to be efficacious, safe and well tolerated as monotherapies. The artemisinin-naphthoquine combination offers a novel advantage over existing ACTs: it can be administered as a single oral dose (or a 1-day treatment). Several therapeutic studies conducted recently indicate that a single oral dose administration of artemisinin-naphthoquine combination is equally effective and safe as the 3-day treatment with artemether-lumefantrine combination and other existing ACTs. This would make ARCO® the next generation ACT for the treatment of uncomplicated falciparum malaria.
Keywords: artemisinin-naphthoquine combination; ARCO; artemisinin; naphthoquine; Plasmodium falciparum

Article Statistics

Load and display the download statistics.

Citations to this Article

Cite This Article

MDPI and ACS Style

Hombhanje, F.W.; Huang, Q. Artemisinin-Naphthoquine Combination (ARCO®): An Overview of the Progress. Pharmaceuticals 2010, 3, 3581-3593.

AMA Style

Hombhanje FW, Huang Q. Artemisinin-Naphthoquine Combination (ARCO®): An Overview of the Progress. Pharmaceuticals. 2010; 3(12):3581-3593.

Chicago/Turabian Style

Hombhanje, Francis W.; Huang, Qingyun. 2010. "Artemisinin-Naphthoquine Combination (ARCO®): An Overview of the Progress." Pharmaceuticals 3, no. 12: 3581-3593.

Pharmaceuticals EISSN 1424-8247 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert